CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

Tocilizumab 20 MG/ML

Phase 2
Roche Holding AG (RHHBY)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
RHHBYPhase 2

Tocilizumab 20 MG/ML Phase 2 Est. Readout

Tocilizumab 20 MG/ML
Dec 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Sars-CoV2

View Full Landscape
Drug Information

Target Indication

Sars-CoV2

Clinical Trial

NCT04363853

Last updated: 8/19/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.